Annual review issue: Urologic pathology: a remarkable journey of innovation.
作者信息
Cheng Liang, Berney Daniel M
机构信息
Indiana University, Indianapolis, USA.
Department of Cellular Pathology, Barts and The London School of Medicine and Dentistry, London, UK.
出版信息
Histopathology. 2019 Jan;74(1):3. doi: 10.1111/his.13777.
PMID:30565305
Abstract
摘要
相似文献
1
Annual review issue: Urologic pathology: a remarkable journey of innovation.
Histopathology. 2019 Jan;74(1):3. doi: 10.1111/his.13777.
2
[New therapies for urologic cancer diseases. The Danish Society of Urology].
Ugeskr Laeger. 2008 Mar 17;170(12):1057.
3
[News with clinical relevance from major scientific meetings 2014 - Update Urooncology].
Aktuelle Urol. 2015 Mar;46(2):106-17. doi: 10.1055/s-0035-1549871. Epub 2015 Apr 24.
4
[Update urooncology: news with clinical relevance from major scientific meetings 2012].
Aktuelle Urol. 2012 Dec;43(6):376-87. doi: 10.1055/s-0032-1332786. Epub 2012 Dec 19.
5
Controversies in urologic oncology.
Iowa Med. 1991 Aug;81(8):343-5.
6
Urological tumours: recent changes.
Aust N Z J Surg. 1995 May;65(5):350-8. doi: 10.1111/j.1445-2197.1995.tb00654.x.
7
[An 18-year follow-up of a patient with four asynchronous malignant tumors of the urogenital system].
Urologiia. 2014 Jan-Feb(1):68-72.
8
Perspectives on Geriatric Oncology Research presented at the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium.
J Geriatr Oncol. 2019 Jul;10(4):523-525. doi: 10.1016/j.jgo.2019.04.005. Epub 2019 Apr 11.
9
[Monoclonal antibodies in diagnosis and therapy].
Immun Infekt. 1989 Feb;17(1):28.
10
Next revolution in molecular theranostics: personalized medicine for urologic cancers.
Future Oncol. 2015;11(15):2205-19. doi: 10.2217/fon.15.104.
Zotero 插件